Khi được bạn cho phép, chúng tôi sử dụng phân tích giới hạn, chú trọng quyền riêng tư để hiểu hành trình nghiên cứu nào hiệu quả. Chúng tôi không dùng trình theo dõi quảng cáo hoặc ghi lại phiên. Bạn có thể thay đổi lựa chọn này trong Tùy chọn. Đọc Chính sách quyền riêng tư.
Quote this valuation with its source: Fair value, Potential value and the price at analysis.
FAQ
EMN — frequently asked questions
Is Eastman Chemical Company overvalued?
In our latest published analysis dated 2026-10-15, EMN looks modestly undervalued. The price recorded at analysis is 62,9 USD versus our fair value of 70,1 USD; the high endpoint is presented separately as potential value of 91,3 USD. That implies roughly 11.4% upside to fair value at that date.
Our latest published report, analyzed 2026-10-15, gives EMN a fair value of 70,1 USD and a potential value of 91,3 USD. The conclusion is triangulated across multiple valuation models and weighted by reliability for Eastman Chemical Company's archetype; it is a dated research output, not a live price.
Should I buy EMN now?
Our latest published rating for EMN, analyzed 2026-10-15, is Buy. Eastman Chemical Company looks modestly undervalued at the analysis-date price of 62,9 USD versus fair value of 70,1 USD; potential value is 91,3 USD. This is research for educational purposes, not personalized investment advice.
What are the biggest risks for EMN?
The dedicated bear-case section in our report analyzed 2026-10-15 documents Eastman Chemical Company's material risks, evidence, thresholds, and thesis-invalidation conditions. Scenario-specific explanations remain in that section so the report does not repeat or decontextualize them elsewhere.
What is EMN's rating?
Our latest published rating for EMN, analyzed 2026-10-15, is Buy, with a published moat assessment of 6.5/10 (Narrow). It reflects our fair value of 70,1 USD, the potential value of 91,3 USD, and the price recorded at analysis (62,9 USD).
Báo cáo này chưa được dịch. Hãy làm mới sau vài phút khi hàng đợi dịch xử lý xong.
§1 Tóm tắt điều hànhEN
Câu trả lời trong 30 giâyBuy
Giá so với giá trị
Giá
$62.88
Giá trị hợp lý
$70.07
Giá trị tiềm năng
$91.33
Tính đến
2026-10-14
Vì sao luận điểm có thể đúng
Successful commercialization and full capacity ramp of Kingsport molecular recycling operations, delivering mix-accretive circular polymers with above-average variable margins.
Điều gì sẽ thay đổi quan điểm của chúng tôi
Severe feedstock spread compression in Chemical Intermediates combined with synchronized global industrial manufacturing stagnation.
We rate Eastman Chemical Company Buy with an intrinsic Fair value of $70.07, representing 11.4% upside from the analysis price of $62.88 as operating margins recover from cyclical lows.
The house rating is Buy. For an investor, this recommendation indicates an attractive opportunity to build exposure to a specialty materials leader as multi-year structural cost initiatives and operational volume improvements take hold.
Shares traded at $62.88 on $62.88 (as of 2026-10-14), standing at an appealing discount to our Fair value of $70.07 and well below our Potential value of $91.33. This gap provides 11.4% upside to the midpoint as cyclical earnings power normalizes.
The primary investment risk is prolonged macroeconomic weakness in Chemical Intermediates, where segment sales stood at $1,925 million in FY2025, combined with customer destocking across global end markets. If raw material and energy inflation outpace contract adjustments, consolidated could remain depressed below the 8.87% level recorded in FY2025.
The central catalyst for value creation is the realization of $125 million to $150 million in affirmed net structural cost reductions for 2026, combined with the operational ramp of the Kingsport molecular recycling facility toward full capacity. Expanding high-margin recycled polymer output upgrades product mix and drives earnings toward consensus FY2027 diluted EPS of $6.79.1,4
Structural Cost Transformation
Management affirmed delivery of $125 million to $150 million in net structural cost reductions for 2026, directly expanding operating margins from cyclical lows.4
Proprietary Molecular Recycling Scale
Plant trials confirm operational capability to ramp Kingsport rPET to full capacity, delivering premium margin mix to Advanced Materials.4
Disciplined Specialty Pricing and Contract Protection
Formulaic pass-through agreements cover raw material, energy, and logistics inflation, preserving market share and cash flow stability.4
Khuyến nghị của hãng
We recommend a Buy rating because structural cost reductions and commercial scaling in circular specialty plastics provide 11.4% upside to our Fair value of $70.07.
Tổng quan công ty
Eastman Chemical Company is a global specialty materials producer that manufactures differentiated chemicals, fibers, and performance plastics. The company operates through four principal segments: Additives & Functional Products, Advanced Materials, Chemical Intermediates, and Fibers.
The company leverages integrated technology platforms across cellulosic biopolymer, acetyl, olefins, polyester, and alkylamine streams to manufacture high-value specialty products with cost-advantaged scale. Chemical Intermediates consumes key feedstock streams to support internal specialty operations while selling surplus intermediate chemicals into industrial, construction, and consumer packaging markets.
Eastman serves a diversified global customer base across transportation, building and construction, consumer goods, and agriculture, generating $3,662 million in domestic sales and $4,140 million across international markets in FY2025.
§2 Kịch bản tiêu cựcEN
In a severe cyclical downturn, prolonged end-market weakness in Chemical Intermediates from Middle East logistics tensions combines with extended customer hesitation to build inventories. If technical line-out hurdles at Kingsport further delay commercial rPET volume shipments, consolidated operating margins remain depressed near FY2025's 8.87% level. Under these stress conditions, earnings per share would fail to reach the consensus FY2026 forecast of $6.35, testing downside valuation levels near $50.80.
The downside path contemplates extended industrial contraction, severe raw material spread compression, and delayed commercialization of molecular recycling assets. Under these conditions, customer destocking persists across domestic and foreign end markets while feedstock cost inflation erodes profitability in intermediate chemical chains. The reader would identify this path unfolding through declining segment volumes, persistent plant turnaround cost overruns, and an inability to maintain price discipline during contract renewals over the coming fiscal periods.
Các cách luận điểm này có thể đổ vỡ
Severe Feedstock Spread Compression and Plant Turnaround Cost Overruns
Energy headwinds and raw material inflation compress product spreads while utilizations remain depressed, exacerbated by Middle East logistics disruptions in Chemical Intermediates and $40M-$45M in quarterly turnaround headwinds, driving operating margins below FY2025's 8.87% EBIT level.3,4
FV impact
0%
Operating margin 3 points lower throughout
Trigger
Within 12 months
Tín hiệu cảnh báo sớm cần theo dõi
Năm diễn biến có thể làm suy yếu luận điểm đầu tư của chúng tôi.
Operating margin fails to rebound into the 11.0% to 12.0% range, indicating structural cost savings of $125M-$150M are being absorbed by raw material inflation and turnaround costs.
Hiện tại:8.87% in FY2025
Cảnh báo nếuBelow 9.0% in FY2026
02
§3 Lợi thế cạnh tranhEN
Narrow
Eastman Chemical Company possesses a Narrow economic moat underpinned by customer switching costs in formulated specialty additives and proprietary technology platforms in advanced circular polymers. The company's specialty portfolio is tightly integrated with customer manufacturing processes in high-specification end markets such as automotive interlayers, aviation fluids, and medical packaging, creating significant friction and qualification barriers for competing alternatives.
The competitive advantage is reinforced by cost advantages stemming from large-scale vertical integration across cellulosic biopolymer, acetyl, and olefins chemical streams. By supplying internal feedstock requirements to downstream specialty businesses at advantaged cost, Eastman protects variable margins while commercializing surplus intermediates in global merchant markets.
Pricing discipline and contractual cost pass-through mechanisms further defend the company's economic returns. During inflationary periods, formulaic pass-through agreements across specialty lines insulate earnings from raw material and energy cost surges without incurring market share losses.
Lợi nhuận kinh tế
Eastman's mid-cycle normalized returns on invested capital are positioned to exceed its moderate cost of equity of 9.63%, established via a risk-free rate of 5.21%, an equity risk premium of 4.20%, and an adjusted beta of 1.0535. While FY2025 EBIT of $776 million reflected cyclical trough conditions, economic profits are expected to expand as operating margins recover toward 11.0% to 12.0%.2,3
6.5/ 10
Narrow
Sources of advantage
01Customer Switching Costs — Specialty interlayers and performance additives are embedded into mission-critical customer specifications in aviation, automotive, and packaging applications, where formulaic cost pass-through agreements support margin stability.Moderate
02Cost Advantage via Vertical Integration — Integrated production streams across cellulosic biopolymers, acetyls, and olefins enable high asset utilization and low unit conversion costs, supplying captive feedstocks to specialty units.Moderate
03Intangible Assets and Process Technology — Proprietary polyester renewal molecular recycling technology operating at Kingsport provides differentiated, drop-in circular plastics with variable margins above the corporate average.
Mối đe dọa đã biết với lợi thế cạnh tranh
Mối đe dọa
Mức độ
Mốc thời gian
Giảm thiểu
Volatile raw material and energy input costs compressing intermediate product spreads
medium
6 to 12 months
Formulaic contractual cost pass-throughs and disciplined price increases implemented across commercial accounts.4
The highlighted cell is Fair value when every assumption sits at its base level ($70.07). Each row and column shows what Fair value becomes when one assumption moves.
Global industrial manufacturing demand reaccelerates sharply, driving strong volume recovery across specialty segments.
Kingsport circular renewal facility reaches full nameplate capacity with premium product mix realization.
Formulaic cost pass-through agreements preserve price realization while raw material and energy costs decline.
In the upside path, shares reach $91.33 with an estimated probability of 20.0%, offering an implied return of 45.2% from $62.88. This scenario requires global industrial activity to reaccelerate rapidly, lifting volume demand across specialty additives and advanced materials. Simultaneously, the Kingsport circular plastics platform must ramp seamlessly to full nameplate capacity, capturing premium mix pricing from major consumer brands. Disconfirmation would occur if quarterly volume growth stalls or if customer price increases are rolled back under peer competitive pressure by the middle of FY2027.
Management achieves affirmed net structural operating expense reductions across the organization.
Commercial ramping at Kingsport progresses through mechanical line-out stages toward full utilization.
§7 Cây quyết định lợi nhuậnEN
Vượt
Maintain Buy; Maintain position and evaluate expanding allocation toward maximum portfolio limits while verifying that volume acceleration extends into subsequent quarters.
Kích hoạt: Consolidated quarterly revenue and operating profit exceed consensus expectations, accompanied by operating margin expansion above normalized target trajectories.
A quarterly beat indicates accelerated operational absorption from structural cost reduction programs alongside rapid customer adoption of molecular recycling volumes, validating faster earnings normalization.
Đúng kỳ vọng
Maintain Buy; Rebalance position in line with portfolio risk limits and continue tracking circular polymer facility utilization milestones.
Kích hoạt: Quarterly financial results meet consensus revenue and earnings expectations, with operating margins tracking within projected recovery ranges.
In-line execution demonstrates that affirmed net cost savings are being delivered as scheduled and that specialty pricing power remains intact despite ongoing macroeconomic caution.
Hụt
Downgrade the rating; Pause additional capital deployment, reassess the operational timeline for Kingsport facility commercialization, and review downside protection thresholds.
Kích hoạt: Quarterly revenue contracts and operating margins decline below cyclical trough levels due to unrecovered raw material inflation or plant turnaround overruns.
A significant quarterly shortfall would indicate that cost takeouts are being overwhelmed by feedstock inflation or that mechanical bottlenecks at the circular recycling plant are worsening.
Chất lượng lợi nhuận
Earnings quality is supported by solid cash conversion through cyclical trough conditions, with operating cash flow continuing to exceed net income. Working capital management remains disciplined, and inventory balances are actively aligned with customer ordering patterns. High contractual cost pass-through coverage across formulated specialty lines reinforces gross margin durability, ensuring that reported earnings accurately reflect underlying operational performance rather than accounting accruals.
Xu hướng dự báo
Consensus analyst revisions have stabilized following recent earnings disclosures, reflecting balanced expectations as affirmed structural cost savings offset near-term macroeconomic slowness.
Hiện tạiManagement has affirmed net structural cost reduction delivery while implementing disciplined price increases across specialty lines.
Vì sao quan trọng
Operating margin expansion reveals whether structural cost reductions are dropping to the bottom line or being consumed by input cost inflation, directly driving mid-cycle earnings power per share.
Eastman demonstrated resilient cash generation during cyclical trough conditions, producing $970 million in operating cash flow and $424 million in free cash flow in FY2025. Operating income reached $931 million, supporting ongoing capital expenditure of $546 million against depreciation of $513 million. As management delivers on $125 million to $150 million in affirmed net structural cost reductions for 2026 and working capital needs stabilize, operating cash conversion is expected to strengthen meaningfully.3,4,5,6
Return on invested capital is troughing following cyclical margin compression in FY2025 where EBIT was $776 million. ROIC is projected to expand steadily over the five-year forecast horizon as operating margins expand from 8.87% toward 12.0% on structural cost takeouts and higher circular specialty plant utilization.
Normalized mid-cycle ROIC is projected to comfortably exceed Eastman's moderate cost of equity of 9.63%, derived from a 5.21% risk-free rate, 4.20% equity risk premium, and 1.0535 adjusted beta, confirming positive economic value added across the cycle.
Doanh thu mới nhất8,8 T US$CAGR doanh thu −0,3%
Biên hoạt động10,6%10 kỳ tài chính
Dòng tiền tự do mới nhất424 Tr US$FY2025
Nợ ròng4,5 T US$FY2025
Phân tích báo cáo kết quả kinh doanhQuy mô kinh doanh chuyển thành lợi nhuận báo cáo như thế nào.30 thg 6, 2026
StockMarketAgent.AI
Doanh thu2,5 T US$Giá vốn doanh thu−2 T US$Lợi nhuận gộp560 Tr US$Chi phí hoạt động−250 Tr US$Lợi nhuận hoạt động310 Tr US$Các khoản ngoài hoạt động và thuế−127 Tr US$Lợi nhuận ròng183 Tr US$
Dữ liệu lịch sử tài chính
Doanh thu
2.513.000.000 US$
Giá vốn doanh thu
1.953.000.000 US$
Lợi nhuận gộp
560.000.000 US$
Chi phí hoạt động
250.000.000 US$
Lợi nhuận hoạt động
310.000.000 US$
Các khoản ngoài hoạt động và thuế
-127.000.000 US$
Lợi nhuận ròng
183.000.000 US$
Tổng quan bảng cân đối kế toánCách tài sản đã báo cáo được nắm giữ và tài trợ trong kỳ đã chọn.
StockMarketAgent.AI
Cơ cấu tài sảnNguồn tài trợ
Tổng tài sản14,9 T US$Tiền mặt566 Tr US$Tài sản ngắn hạn3,6 T US$Tổng nợ phải trả8,8 T US$Nợ ngắn hạn2,7 T US$Vốn chủ sở hữu6 T US$
Dữ liệu phân tích bảng cân đối kế toán
Tổng tài sản
14.859.000.000 US$
Tiền mặt
566.000.000 US$
Tài sản ngắn hạn
3.645.000.000 US$
Tổng nợ phải trả
8.822.000.000 US$
Nợ ngắn hạn
2.652.000.000 US$
Vốn chủ sở hữu
6.037.000.000 US$
Cầu nối dòng tiềnDòng tiền từ hoạt động chuyển thành dòng tiền tự do như thế nào trong FY2025.
StockMarketAgent.AI
Đối chiếu dòng tiền hoạt động
Lợi nhuận ròng474 Tr US$Khấu hao và phân bổ+513 Tr US$Điều chỉnh hoạt động khác−17 Tr US$Dòng tiền hoạt động970 Tr US$
Đối chiếu tiền đầu kỳ đến cuối kỳ
Tiền đầu kỳ837 Tr US$Dòng tiền hoạt động+970 Tr US$Dòng tiền đầu tư−462 Tr US$Dòng tiền tài chính−797 Tr US$Ảnh hưởng tỷ giá+18 Tr US$Tiền cuối kỳ566 Tr US$
970 Tr US$ − 546 Tr US$Dòng tiền tự do 424 Tr US$
Dữ liệu cầu nối dòng tiền
Lợi nhuận ròng
474.000.000 US$
Dòng tiền vào từ hoạt động
987.000.000 US$
Khấu hao và phân bổ
513.000.000 US$
Dòng tiền hoạt động
970.000.000 US$
Dòng tiền ra từ hoạt động
17.000.000 US$
Tiền sẵn có
1.825.000.000 US$
Tiền đầu kỳ
837.000.000 US$
Ảnh hưởng tỷ giá
18.000.000 US$
Dòng tiền ra từ đầu tư
462.000.000 US$
Dòng tiền ra từ tài chính
797.000.000 US$
Mua lại cổ phiếu
100.000.000 US$
Cổ tức đã trả
381.000.000 US$
Hoàn trả nợ ròng
304.000.000 US$
Hoạt động tài chính khác
12.000.000 US$
Tiền cuối kỳ
566.000.000 US$
Dòng tiền đầu tư
-462.000.000 US$
Dòng tiền tài chính
-797.000.000 US$
Doanh thu theo phân khúc hoạt độngTỷ trọng trong tổng doanh thu của 2025-12-31.
8,8 T US$Tổng doanh thu
Doanh thu theo phân khúc hoạt độngTỷ trọng
Additives And Functional Products2,9 T US$32,9%+0,6% so với cùng kỳ
Advanced Materials2,9 T US$32,9%−5,6% so với cùng kỳ
Chemical Intermediates1,9 T US$22%−9,8% so với cùng kỳ
Fibers1,1 T US$12%−20,3% so với cùng kỳ
Nguồn: SEC EDGAR · Nộp ngày 2026-02-13 · SEC EDGAR
Dữ liệu cơ cấu doanh thu: Doanh thu theo phân khúc hoạt động
Doanh thu theo phân khúc hoạt động
Doanh thu
Tỷ trọng
so với cùng kỳ
Additives And Functional Products
2,9 T US$
32,9%
0,6%
Advanced Materials
2,9 T US$
32,9%
-5,6%
Chemical Intermediates
1,9 T US$
22%
-9,8%
Fibers
1,1 T US$
12%
-20,3%
Doanh thu theo khu vựcTỷ trọng trong tổng doanh thu của 2025-12-31.
8,8 T US$Tổng doanh thu
Doanh thu theo khu vựcTỷ trọng
All Foreign4,1 T US$47,3%−8,7% so với cùng kỳ
United States3,7 T US$41,8%−2,9% so với cùng kỳ
China950 Tr US$10,9%−11,5% so với cùng kỳ
Nguồn: SEC EDGAR · Nộp ngày 2026-02-13 · SEC EDGAR
Dữ liệu cơ cấu doanh thu: Doanh thu theo khu vực
Doanh thu theo khu vực
Doanh thu
Tỷ trọng
so với cùng kỳ
All Foreign
4,1 T US$
47,3%
-8,7%
United States
3,7 T US$
41,8%
-2,9%
China
950 Tr US$
10,9%
-11,5%
Doanh thu và lợi nhuậnQuy mô kinh doanh chuyển thành lợi nhuận báo cáo như thế nào.
Tiền mặt và nợThanh khoản sẵn có so với tổng dư nợ.
Tạo dòng tiềnDòng tiền hoạt động so với dòng tiền tự do.
Khả năng sinh lờiDiễn biến biên gộp, biên hoạt động và biên ròng.
Dữ liệu tài chính tại thời điểm được dùng trong phân tích ngày 2026-10-15.
Dữ liệu lịch sử tài chính
Kỳ
Doanh thu
EBITDA
Lợi nhuận ròng
Dòng tiền hoạt động
Dòng tiền tự do
Capex
Khấu hao và phân bổ
Thù lao bằng cổ phiếu
Mua lại cổ phiếu
Cổ tức đã trả
Phát hành nợ ròng
Dòng tiền đầu tư
Dòng tiền tài chính
Tiền đầu kỳ
Tiền cuối kỳ
Tiền mặt và đầu tư
Tổng nợ
Biên hoạt động
ROIC
WACC
Chênh lệch ROIC−WACC
2016-12-31
9 T US$
1,9 T US$
854 Tr US$
1,4 T US$
759 Tr US$
626 Tr US$
580 Tr US$
36 Tr US$
—
272 Tr US$
—
-655 Tr US$
-838 Tr US$
—
181 Tr US$
182 Tr US$
6,6 T US$
15,4%
—
6,1%
—
2017-12-31
9,5 T US$
2,1 T US$
1,4 T US$
1,7 T US$
1 T US$
649 Tr US$
587 Tr US$
52 Tr US$
—
296 Tr US$
—
-643 Tr US$
-1 T US$
181 Tr US$
191 Tr US$
192 Tr US$
6,5 T US$
16,0%
—
5,9%
—
2018-12-31
10,2 T US$
2,1 T US$
1,1 T US$
1,5 T US$
1 T US$
528 Tr US$
604 Tr US$
64 Tr US$
—
318 Tr US$
—
-463 Tr US$
-1 T US$
191 Tr US$
226 Tr US$
227 Tr US$
6,2 T US$
14,5%
—
5,8%
—
2019-12-31
9,3 T US$
1,7 T US$
759 Tr US$
1,5 T US$
1,1 T US$
425 Tr US$
611 Tr US$
96 Tr US$
—
343 Tr US$
—
-480 Tr US$
-1 T US$
226 Tr US$
204 Tr US$
205 Tr US$
5,8 T US$
14,3%
—
5,4%
—
2020-12-31
8,5 T US$
1,3 T US$
478 Tr US$
1,5 T US$
1,1 T US$
383 Tr US$
574 Tr US$
387 Tr US$
—
358 Tr US$
—
-394 Tr US$
-704 Tr US$
204 Tr US$
564 Tr US$
565 Tr US$
5,6 T US$
13,3%
—
5,1%
—
2021-12-31
10,5 T US$
1,8 T US$
857 Tr US$
1,6 T US$
1,1 T US$
555 Tr US$
538 Tr US$
302 Tr US$
900 Tr US$
375 Tr US$
—
-29 Tr US$
-1,7 T US$
564 Tr US$
459 Tr US$
485 Tr US$
5,5 T US$
14,0%
—
5,7%
—
2022-12-31
10,6 T US$
1,6 T US$
793 Tr US$
975 Tr US$
364 Tr US$
611 Tr US$
477 Tr US$
-103 Tr US$
1 T US$
381 Tr US$
76 Tr US$
392 Tr US$
-1,3 T US$
459 Tr US$
493 Tr US$
494 Tr US$
5,2 T US$
10,2%
—
7,7%
—
2023-12-31
9,2 T US$
1,6 T US$
894 Tr US$
1,4 T US$
546 Tr US$
828 Tr US$
498 Tr US$
65 Tr US$
150 Tr US$
376 Tr US$
-338 Tr US$
-432 Tr US$
-888 Tr US$
493 Tr US$
548 Tr US$
549 Tr US$
5,1 T US$
11,9%
—
8,0%
—
2024-12-31
9,4 T US$
1,8 T US$
905 Tr US$
1,3 T US$
688 Tr US$
599 Tr US$
509 Tr US$
99 Tr US$
300 Tr US$
379 Tr US$
198 Tr US$
-534 Tr US$
-454 Tr US$
548 Tr US$
837 Tr US$
837 Tr US$
5,3 T US$
14,7%
—
8,5%
—
2025-12-31
8,8 T US$
1,3 T US$
474 Tr US$
970 Tr US$
424 Tr US$
546 Tr US$
513 Tr US$
—
100 Tr US$
381 Tr US$
-304 Tr US$
-462 Tr US$
-797 Tr US$
837 Tr US$
566 Tr US$
566 Tr US$
5,1 T US$
10,6%
—
7,4%
—
§9 So sánh định giá với các doanh nghiệp cùng ngành
Giá trị hợp lýReport-date price
Eastman Chemical CompanyEMN
Giá / giá trị hợp lý
Giá trị hợp lý70,07 US$Report-date price62,88 US$
Ngày đánh giá
Hào kinh tếNarrow
Bảng điểm đầu tư62 / 100
DuPont de Nemours, Inc.DD
Giá / giá trị hợp lý
Giá trị hợp lý100,11 US$Report-date price130 US$
Ngày đánh giá
Hào kinh tếNarrow
Bảng điểm đầu tư54 / 100
Albemarle CorporationALB
Giá / giá trị hợp lý
Giá trị hợp lý108,19 US$Report-date price98,51 US$
Eastman Chemical Company (EMN) trades at 9.2x forward earnings against a peer median of 14.1x. Its EV/EBITDA of 8.6x compares with a peer median of 11.4x. The comparison uses 4 peers: DuPont de Nemours Inc., Albemarle Corporation, International Flavors & Fragrances Inc. and PPG Industries Inc., as of 2026-10-15.
§10 Ngành và chu kỳEN
Pha chu kỳ
Trough
The basic materials sector displays capital discipline, with industry capex-to-depreciation standing at 1.55 and industry capex-to-revenue at 4.1%, while industry operating margins average 12.4%. Eastman's own capital expenditure of $546 million aligned closely with depreciation of $513 million, demonstrating disciplined capacity additions.
Chu kỳ tăng giá
An upturn driven by global industrial manufacturing reacceleration, end-market inventory restocking, and expanding price-cost spreads, propelling Eastman's operating margins above the industry benchmark of 12.4%.
Chu kỳ giảm giá
A protracted cyclical downturn characterized by persistent high energy feedstocks, customer destocking, and weak building and construction demand, holding operating margins below 9.0%.
Xu hướng dài hạn
Xu hướng
Tác động
Ghi chú
Transition to Circular Plastics and Sustainable Packaging
positive
Rising regulatory mandates and brand owner sustainability commitments drive sustained demand for certified recycled polymers, positioning Eastman's Kingsport polyester renewal technology for premium growth.
High-Performance Materials Formulations
positive
Expanding demand for advanced interlayers in automotive acoustic and heads-up display applications, alongside specialty films, creates long-term volume tailwinds for Advanced Materials.
Định vị
Eastman is strategically positioned as a differentiated specialty producer with 41.8% of FY2025 revenues generated in the United States and 47.3% across international markets. Its contractual pass-through structures and proprietary molecular recycling platform allow it to defend margins better than pure commodity peers.4,7
§11 Quản lý vị thếEN
Quy mô vị thế
3-4%
A moderate position weighting reflects the attractive upside toward our Fair value balanced against cyclical exposure in chemical intermediates and near-term line-out pacing in circular plastics.
Rủi ro
Risk management centers on monitoring gross margin durability across raw material price cycles and verifying the execution of affirmed cost takeout milestones. Capital should be allocated in staggered tranches to mitigate downside from broader industrial manufacturing weakness, while portfolio exposure is capped within disciplined cyclical sector guidelines.
Đợt vào lệnh
Mức
Hành động
Lý do
$62.88
Initiate Primary Tranche
Establish initial position at $62.88 as share prices trade at a meaningful discount offering 11.4% upside to Fair value.
Extended pullback
Accumulate Secondary Tranche
Deploy additional capital on extended pullbacks, securing an expanded margin of safety against cyclical intermediate volatility.
Eastman trades at an attractive valuation relative to normalized mid-cycle earnings power, providing 11.4% upside to Fair value as operating profit recovers.
Specialty Turnaround Investor
Buy
Management's delivery on structural cost savings programs alongside pricing discipline provides clear operational leverage as customer order volumes normalize.
Long-Term Sustainability Investor
Buy
Proprietary molecular recycling infrastructure establishes a durable competitive moat in circular plastics, capturing high-margin premium demand over a multi-year horizon.
§14 Khuyến nghị cuối cùngEN
Hành động
Mua
We recommend a Buy rating on Eastman Chemical Company. Shares traded at $62.88 on $62.88 (as of 2026-10-14), offering 11.4% upside to our Fair value of $70.07 and substantial long-term optionality toward Potential value of $91.33.
The investment thesis is driven by structural cost reductions, volume recovery across formulated specialty plastics, and margin expansion from commercial molecular recycling operations.
§15Your notes
Capture your own thesis, position size, and follow-up questions. Stays on this device, only you can see it.
Private notes
Visible only to you. Synced to this device.
0 chars
Sources
The records this analysis drew on, as they stood when it was run.
Analyst consensusData as of 2026-10-15 · Published 2026-10-15 · Provider-adjusted · cited for 3 figuresCited in Tóm tắt điều hành, Kịch bản tiêu cực
Not every cited input appears here: internal calculations and intermediate model outputs have no external record, and some citations could not be matched to one.
Cyclical Valuation Derating on Persistent Commodity Mix Drag
Sluggish customer adoption in specialty packaging and weakness in Chemical Intermediates cause the market to re-rate Eastman toward commodity chemical peers like Albemarle at 8.7x rather than specialty multiples, compressing the terminal P/E from 11.0x.3,7
FV impact
-6.5%
Terminal multiple 20% lower
Trigger
Within 18 months
Synchronous Global Industrial Stagnation and Customer Destocking
Management reports widespread macroeconomic weakness across both domestic and foreign markets with customers unwilling to build inventory, while Kingsport rPET line-out challenges constrain volume ramp, invalidating the projected FY2026 revenue rebound to $9.26B.1,4,7
FV impact
-2%
Revenue and EPS growth 5 points lower for five years
Synchronous economic weakness across the United States ($3,662 million in FY2025) and foreign markets ($4,140 million in FY2025) prevents volume recovery.
Project revenue, apply a terminal EV/revenue multiple, discount enterprise value, subtract net debt, and divide by diluted shares.
How this lens was calculated
Inputs used in this report
North American and European industrial end-market demand normalizes without severe recessionary shock.
The modal path projects shares achieving $70.07 with an estimated probability of 55.0%, generating an implied return of 11.4% relative to $62.88. For this path to unfold, management must execute on affirmed structural cost savings programs while operational line-out progress at the Kingsport facility enables orderly volume expansion across FY2026 and FY2027. This path would be disconfirmed if operating margins fail to expand above cyclical trough levels or if customer destocking in chemical intermediates persists past the conclusion of FY2026.
Mechanical line-out challenges prompted initial pacing adjustments, but plant testing has demonstrated operational capability to run at full capacity.
Vì sao quan trọng
Operational ramp to full capacity demonstrates commercial viability of the circular technology, unlocking mix-accretive variable margins and lifting Advanced Materials profitability.
03
Chỉ số:
Chemical Intermediates Product Spreads
Hiện tạiMargins face moderation from regional logistics friction and energy cost volatility in overseas markets.
Vì sao quan trọng
Spread health in acetyls and olefins indicates basic chemical supply-demand balance, driving segment cash generation and preventing negative earnings drag on specialty units.
04
Chỉ số:
Customer Order Volumes and Restocking Patterns
Hiện tạiCustomers maintain lean inventories amidst macroeconomic caution, with order patterns reflecting cautious near-term commitments.
Vì sao quan trọng
Shifts from cautious hand-to-mouth purchasing toward order restocking reveal underlying industrial demand inflection, accelerating consolidated revenue growth.
Eastman maintains a disciplined, shareholder-focused capital allocation framework. Historically, management deployed capital into synergistic specialty acquisitions such as Solutia and Taminco at disciplined valuations around 9x EBITDA. The current strategy emphasizes organic growth investments, notably scaling the Kingsport circular facility toward 100% capacity, alongside sustaining a reliable common dividend and executing opportunistic share repurchases as diluted shares outstanding stood at 115.6 million at year-end FY2025.
Giá trị hợp lý99,48 US$Report-date price105,07 US$
Ngày đánh giá
Hào kinh tếNarrow
Bảng điểm đầu tư61 / 100
Biên
EMN
Eastman Chemical Company
$7.2B
9.2x
0.8x
8.6x
7.3%
—
DD
DuPont de Nemours Inc.
$17.3B
16.1x
2.5x
11.9x
1.8%
14.2%
ALB
Albemarle Corporation
$11.6B
8.7x
2.0x
9.7x
2.6%
27.7%
IFF
International Flavors & Fragrances Inc.
$22.9B
22.6x
2.1x
15.0x
-5.5%
8.5%
PPG
PPG Industries Inc.
$23.3B
12.2x
1.4x
10.9x
19.3%
14.0%
Geopolitical and Regional Supply Chain Realignment
neutral
Ongoing trade friction and regional logistics disruptions increase the value of domestic North American supply security ($3,662 million revenue) while introducing volatility into foreign intermediate exports ($4,140 million revenue).
Reassess commercial adoption rate of Kingsport circular rPET and reduce exposure.
